160 related articles for article (PubMed ID: 9380768)
1. Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats.
Huang YT; Liu TB; Lin HC; Yang MC; Hong CY
Pharmacology; 1997 May; 54(5):225-31. PubMed ID: 9380768
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats.
Huang YT; Tsai JF; Lin HC; Chen CF; Hong CY
Can J Physiol Pharmacol; 1997; 75(10-11):1220-5. PubMed ID: 9431446
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic effects of chronic octreotide and tetrandrine administration in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Chen SM; Hong CY
J Gastroenterol Hepatol; 1998 Mar; 13(3):266-72. PubMed ID: 9570239
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Chen CF; Hong CY
J Gastroenterol Hepatol; 1997 Aug; 12(8):585-9. PubMed ID: 9304511
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY
Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131
[TBL] [Abstract][Full Text] [Related]
6. Portal hypotensive effects of tetrandrine and verapamil in portal hypertensive rats.
Liu TB; Lin HC; Huang YT; Sun CM; Hong CY
J Pharm Pharmacol; 1997 Jan; 49(1):85-8. PubMed ID: 9120776
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of chronic tetrandrine treatment in Sprague-Dawley rats.
Huang YT; Cheng YR; Lin HC; Chen CF; Hong CY
Chin J Physiol; 1997 Sep; 40(3):175-8. PubMed ID: 9434894
[TBL] [Abstract][Full Text] [Related]
8. Systemic and splanchnic hemodynamics following hemorrhage and volume restitution with Haemaccel in portal hypertensive rats: the effect of propranolol.
Hilzenrat N; Arish A; Yaari A; Sikuler E
J Gastroenterol Hepatol; 2001 Jul; 16(7):796-800. PubMed ID: 11446889
[TBL] [Abstract][Full Text] [Related]
9. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
[TBL] [Abstract][Full Text] [Related]
10. Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(α)-mediated pathway in portal hypertensive rats.
Lee JY; Huo TI; Huang HC; Lee FY; Lin HC; Chuang CL; Chang CC; Wang SS; Lee SD
Clin Sci (Lond); 2011 Dec; 121(12):545-54. PubMed ID: 21736560
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of propranolol improves vascular contractile responsiveness in portal hypertensive rats.
Huang YT; Lin HC; Tsai JF; Hou MC; Hong CY
Eur J Clin Invest; 1997 Jul; 27(7):550-5. PubMed ID: 9263740
[TBL] [Abstract][Full Text] [Related]
12. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
13. Acute hemodynamic effects of tetramethylpyrazine and tetrandrine on cirrhotic rats.
Huang YT; Chang FC; Chen KJ; Hong CY
Planta Med; 1999 Mar; 65(2):130-4. PubMed ID: 10193203
[TBL] [Abstract][Full Text] [Related]
14. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
Oberti F; Rifflet H; Maïga MY; Pilette C; Gallois Y; Douay O; Le Jeune JJ; Saumet JL; Calès P
J Hepatol; 1997 Jan; 26(1):167-73. PubMed ID: 9148008
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.
Chang FC; Huang YT; Lin HC; Hong CY; Lin JG; Chen KJ
Can J Physiol Pharmacol; 1999 Aug; 77(8):618-24. PubMed ID: 10543725
[TBL] [Abstract][Full Text] [Related]
16. Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
Koshy A; Girod C; Lee SS; Hadengue A; Cerini R; Lebrec D
Hepatology; 1989 Feb; 9(2):269-73. PubMed ID: 2912829
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of 8-day DL-028 and octreotide administration in rats with portal hypertension.
Huang YT; Wu HL; Chern JW; Lin HC; Hong CY
Scand J Gastroenterol; 1998 Dec; 33(12):1303-9. PubMed ID: 9930395
[TBL] [Abstract][Full Text] [Related]
18. Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis.
Wang D; Wang Q; Yin J; Dong R; Wang Q; Du X; Lu J
J Gastroenterol Hepatol; 2016 May; 31(5):1037-44. PubMed ID: 26487394
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects of 8-day octreotide and prazosin administration in portal hypertensive rats.
Lin HC; Wu HL; Huang YT; Hou MC; Lee SD; Hong CY
Eur J Clin Invest; 1998 Aug; 28(8):622-8. PubMed ID: 9767356
[TBL] [Abstract][Full Text] [Related]
20. Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.
D'Amico M; Mejías M; García-Pras E; Abraldes JG; García-Pagán JC; Fernández M; Bosch J
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1191-8. PubMed ID: 22403792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
